Stem cell therapy for COPD

Stem cell therapy using pluripotent stem cells and Plurisomes™ offers a regenerative approach for conditions like COPD and pulmonary fibrosis, aiming to repair lung tissue, reduce inflammation, and slow disease progression.

These powerful stem cells release healing signals that help remove lung scarring (fibrosis), improve oxygen flow, and restore breathing function. Plurisomes™ play a key role in rejuvenating damaged areas by activating specific genes, like miR-29, that reverse abnormal tissue scarring.

Patients typically undergo a 4–5 week program that includes daily stem cell IVs, detox therapies, and ozone treatments. While full reversal of severe lung damage may be difficult, many patients experience better breathing, more stamina, and slower disease progression after treatment.

Age or disease stage does not automatically prevent someone from receiving stem cell therapy for COPD or pulmonary fibrosis. The treatment is designed to support healing in people of many ages, from infants to adults in their 80s. What matters most is the patient’s overall health and the severity of their lung condition.

For milder cases, a 4-week program is usually recommended, while advanced COPD or bedridden patients may benefit from an extended 5-week protocol to achieve meaningful results. The therapy aims to reduce inflammation, repair lung tissue, and slow disease progression.

The only major restriction is for patients taking immunosuppressant medications such as Prednisone or Dupixent, which must be stopped before beginning treatment.

Recovery after stem cell therapy for COPD continues well beyond the treatment itself, as the body’s healing mechanisms remain active for three to six months. Although the stem cells are cleared within 48 hours, they release powerful repair signals that keep regenerating lung tissue for months.

In the first two to three weeks, patients may feel mild fatigue or soreness, signs that the body is using its energy for deep healing. Gradually, improvements in breathing, stamina, and energy become more noticeable over time.

A follow-up consultation is usually scheduled around the six-month mark to evaluate progress. Most patients experience lasting benefits, especially when they avoid factors that originally contributed to their lung damage.

Stem cell therapy for COPD focuses on repairing lung tissue, reducing inflammation, and slowing or stopping disease progression. Patients typically experience gradual, long-lasting improvements rather than immediate changes.

Within the first few weeks, the body begins healing at a cellular level, though mild fatigue and temporary discomfort may occur as energy is redirected toward repair. Over three to six months, patients often notice easier breathing, improved oxygen levels, reduced coughing, and better stamina.

The pluripotent stem cells and Plurisomes™ help soften lung scarring, enhance oxygen flow, and support overall vitality. While complete reversal of severe lung damage may not always be possible, most patients experience steady improvement in breathing comfort, energy, and quality of life over time.